
    
      Participants will be enrolled in a 3-step enrollment and randomized to 1 of 4 treatment
      groups. Groups 1 and 2 will receive 5 vaccinations, and Groups 3 and 4 will received 6
      vaccinations (childhood vaccines or placebo co-administered with the first dose of CYD Dengue
      vaccine in 2 separate arms). All toddlers will receive a pentavalent acellular pertussis
      combination vaccine or Combo (PENTAXIMÂ®), planned approximately 10 months after enrollment.
    
  